Test Kits

VACCINATION TEST KIT (26 vials)
(Test Kit VA)

Print this page

The incidence of many of the childhood infectious diseases has declined over the years. This has been attributed to the success of the immunisation programme, but:

• scarlet fever has shown a similar pattern of decline even though there has been no immunisation programme
• many of the infectious diseases were in decline because of improvements in hygiene etc. even before the immunisation programme was introduced
• many doctors will not diagnose a patient as suffering from a particular infection if the patient has been immunised against it, even if the patient is showing all the symptoms of having the disease; sometimes this leads to a “renaming” of diseases, e.g. symptoms of polio in vaccinated people are often classified as aseptic meningitis rather than polio

The risk of immunisation may be much greater than medically recognized because:

• many of the medical studies showing limited side-effects have only looked at the effects for a few days after immunisation
• some of the effect of the vaccination may be there immediately but not easily observable. e.g. has been suggested that immunisation alters the ratio of T-helper cells and T-suppresser cells; this could be a factor in the increase in allergies among children
• some immunisations are only temporary or give partial immunity; they become ineffective during adult life when the complications of the disease are much more dangerous
• natural immunity gives life-time protection; natural immunity is gained from childhood illness when the disease is generally mild in well nourished children (e.g. measles can cause blindness but if Vitamin A is given at the same time the possibilities of complications are dramatically reduced)
• lack of natural immunity could mean that mothers are unable to pass on placental immunity to their babies, making babies too young to be vaccinated susceptible to measles, etc.
• live attenuated viruses are capable of reversion to wild-type parent strains capable of producing disease in inoculated people
• reducing the prevalence of one strain of a virus can allow another possibly more deadly strain to proliferate
• after vaccination cell-mediated immunity is suppressed for a time- this can allow infection in or allow a latent infection to become an acute attack

In U.K. wide scale immunisation against childhood infections began in 1950’s

Code	Vaccine	Type	Vaccination Requirements	Possible Long Term Effects
VA1	B.C.G. (Tuberculosis)	live attenuated	In UK at age 12-13	TB, ME
VA2	Cholera	killed organisms	vaccination only recommended if travelling to cholera areas across remote borders, especially overland.	severe allergic reactions to vaccine, nerve damage, mental problems
VA3	D.P.T. (Diphtheria, Whooping Cough, Tetanus)	toxoids of diphtheria & tetanus; inactivated pertussis	introduced in 1957 in UK, by 1969 over 80% of children vaccinated recommended regime is 4 times before age 6 and then age 14-16 years old, and then every 10 years afterwards	sudden infant death syndrome, brain damage, asthma
VA4	Diphtheria	inactivated bacterial toxins	introduced in 1930’s, now mainly given as DPT
VA5	Diphtheria / Tetanus	inactivated bacterial toxins	now mainly given as DPT
VA6	Encephalitis	inactivated	travel vaccination for Far East, Indian subcontinent, South East Asia
VA7	Hepatitis A		travel vaccination
VA8	Hepatitis B	genetic engineering (yeast or plasma derived)	In New Zealand vaccination of babies introduced in 1988 and abandoned in early 1990’s following evidence of immune suppression; routinely offered to infants in US, but not in UK; compulsory in Italy	ME, arthritis, kidney disease, nerve inflammation, severe skin eruptions, eye problems
VA9	HIB (Bacterial Meningitis caused by Haemophilus Influenzae type b)		introduced in US in 1985 and UK in 1992; given routinely in US at 18 months
VA10	Influenza (various strains) 2	killed organisms		encephalitis, neuritis, optic neuritis, vasulitis and joint problems, reversible paralysis, myelopathy, exacerbate asthma
VA11	Measles	live attenuated	first introduced in UK in 1968 and in US in 1957; banned in UK in August 1999 to force parents to use MMR
VA12	Meningitis	polysaccaride	Saudi Arabia requires immunisation for those going on pilgrimage to Mecca
VA13	MMR (Measles, Mumps and Rubella)	live attenuated	first introduced in UK in 1988 and in US in 1975	autism, Crohn’s disease, seizures
VA14	MR (Measles and Rubella)	live attenuated
VA15	Pertussis (Whooping Cough)	killed organisms	first available in 1912; commonly available mid 1950’s; now mainly given as DPT; compensation for vaccine damage introduced in UK in 1978	brain damage, asthma
VA16	Pneumovax	polysaccaride	given to elderly people to prevent pneumonia a few years ago
VA17	Polio (Sabin)	attenuated live given orally	in use since mid 1960’s, prior to that the Salk polio vaccine was used	weight gain, Guillain-Barre syndrome, ME
VA18	Polio (Salk)	killed organisms given intramuscularly	polio vaccine first introduced in 1952/53 in US and 1956 in UK; the Sabin polio vaccine used in America and England since 1960’s; Finland, Sweden and Netherlands use this polio vaccine
VA19	Rabies	killed organisms	travel vaccination for those exposed to an unusual risk of infection e.g. taking long journeys in the bush
VA20	Rubella (German Measles)	live	rubella during earlier pregnancy can result in damage to unborn child (congenital Rubella Syndrome)	arthritis, polneuralgia, chronic fatigue syndrome
VA21	Smallpox		introduced in England in 1840 and made compulsory in 1853; it is now believed that smallpox has been eradicated so immunisation is no longer required; USA vaccination programme stopped in 1972, re-introduced for selected categories of people in 2003
VA22	TAB (Paratyphoid)	killed organisms
VA23	Tetanus	inactivated bacterial toxins	now mainly given as DPT
VA24	Typhoid	killed organisms
VA25	Yellow Fever	live attenuated
VA26	Meningitis C		First used in UK in clinical trials in 1994; vaccination programme started in 1999 in UK, and from 2000 in Eire

References:
The books by Lynne McTaggart and Leon Chaitow both give homeopathic and nutritional alternatives to vaccination
BMA Complete Family Health Encyclopaedia, Dorling Kindersley, 1998, ISBN 0 86318 438 3
Pamphlet: A Parents Guide To Immunisation produced by Merieux UK ( a vaccine manufacturer)
Trevor Gunn Mass Immunisation: A Point In Question, Cutting Edge Publications,
ISBN 0 9517657 1 X
Lynne McTaggart The Vaccination Bible, What Doctors Don’t Tell You, 1998, ISBN 0 9534 734 0 6
Leon Chaitow Vaccination and Immunisation,C. W. Daniel, 1998, ISBN 0 85207 191 4
Paediatric Clinics Paediatric Vaccinations: update 1990 Volume 37 Number 3
Oxford Text Book of Medicine 3rd Edition Volume 1

Print this page

© Jane Thurnell-Read